Specific nNOS inhibitors for the therapy and prevention of human melanoma

US9090589B2 · kind B2 · utility

Assignees

• Northwestern University · US
• The Regents of the University of California · US

Inventors

• Richard B. Silverman · Winnetka, US
• Frank L. Meyskens, Jr. · Irvine, US
• Sun Yang · Lake Forest, US
• Haitao Ji · Huainan City, CN
• Fengtian Xue · Baton Rouge, US
• Thomas L. Poulos · Irvine, US

Key dates

• Filing date: Feb 3, 2014
• Grant date: Jul 28, 2015
• Expiry date: Feb 3, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.